Annual Total Long Term Liabilities
$6.48 M
+$4.84 M+295.84%
31 December 2023
Summary:
Mereo BioPharma annual total long term liabilities is currently $6.48 million, with the most recent change of +$4.84 million (+295.84%) on 31 December 2023. During the last 3 years, it has fallen by -$88.04 million (-93.15%). MREO annual total long term liabilities is now -93.15% below its all-time high of $94.52 million, reached on 31 December 2020.MREO Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$2.00 M
-$11.00 K-0.55%
30 September 2024
Summary:
Mereo BioPharma quarterly total long term liabilities is currently $2.00 million, with the most recent change of -$11.00 thousand (-0.55%) on 30 September 2024. MREO quarterly long term liabilities is now -97.88% below its all-time high of $94.52 million, reached on 31 December 2020.MREO Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MREO Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +295.8% | - |
| 3 y3 years | -93.2% | -97.3% |
| 5 y5 years | -72.2% | -94.2% |
MREO Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -93.2% | +295.8% | -97.3% | +22.4% |
| 5 y | 5 years | -93.2% | +295.8% | -97.9% | +22.4% |
| alltime | all time | -93.2% | +2992.7% | -97.9% | +856.1% |
Mereo BioPharma Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.00 M(-0.5%) |
| June 2024 | - | $2.01 M(-3.9%) |
| Mar 2024 | - | $2.10 M(-67.6%) |
| Dec 2023 | $6.48 M(+295.8%) | $6.48 M(-5.5%) |
| June 2023 | - | $6.86 M(+319.0%) |
| Dec 2022 | $1.64 M(-95.3%) | $1.64 M(-58.4%) |
| June 2022 | - | $3.93 M(-88.7%) |
| Dec 2021 | $34.92 M(-63.1%) | $34.92 M(-53.6%) |
| June 2021 | - | $75.24 M(-20.4%) |
| Dec 2020 | $94.52 M | $94.52 M(+21.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2020 | - | $77.76 M(+263.5%) |
| Dec 2019 | $21.39 M(-8.0%) | $21.39 M(-37.6%) |
| June 2019 | - | $34.28 M(+47.4%) |
| Dec 2018 | $23.26 M(-29.0%) | $23.26 M(-14.4%) |
| June 2018 | - | $27.18 M(-17.0%) |
| Dec 2017 | $32.75 M(+517.5%) | $32.75 M(+569.5%) |
| June 2017 | - | $4.89 M(-7.8%) |
| Dec 2016 | $5.30 M(+2433.0%) | $5.30 M(-2.1%) |
| June 2016 | - | $5.42 M(+2487.9%) |
| Dec 2015 | $209.40 K | $209.40 K |
FAQ
- What is Mereo BioPharma annual total long term liabilities?
- What is the all time high annual total long term liabilities for Mereo BioPharma?
- What is Mereo BioPharma annual total long term liabilities year-on-year change?
- What is Mereo BioPharma quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Mereo BioPharma?
What is Mereo BioPharma annual total long term liabilities?
The current annual total long term liabilities of MREO is $6.48 M
What is the all time high annual total long term liabilities for Mereo BioPharma?
Mereo BioPharma all-time high annual total long term liabilities is $94.52 M
What is Mereo BioPharma annual total long term liabilities year-on-year change?
Over the past year, MREO annual total long term liabilities has changed by +$4.84 M (+295.84%)
What is Mereo BioPharma quarterly total long term liabilities?
The current quarterly long term liabilities of MREO is $2.00 M
What is the all time high quarterly long term liabilities for Mereo BioPharma?
Mereo BioPharma all-time high quarterly total long term liabilities is $94.52 M